Work

Preclinical and Clinical Resistance Mechanisms To The Investigational Selective FLT3 Inhibitor PLX3397 In FLT3-ITD+ Acute Myeloid Leukemia (AML)

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.3938.3938

Authors: Catherine C Smith, Kimberly Lin, Elisabeth Lasater, Whitney Stewart, Lauren E Damon, Andrew Kasarskis, Ali Bashir, Matthew Pendleton, Robert Sebra, Alexander E Perl, Mai H Le, Chao Zhang, Brian West, Neil P. Shah

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Icahn School of Medicine at Mount Sinai, Abramson Cancer Center, University of Pennsylvania, Plexxikon (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W10819986

FWCI: 0.85

Cites:

Cited by: 7

Related to: 10